Field Testing Dispute Spreads to Europe

PARIS—Europeans this summer have gained intimate experience in an exercise they had viewed in the past as a strictly American sport: genetic engineers versus ecologists. The contest arose after a spate of reports revealed that field tests of modified bacteria and plants were under way in France, West Germany, Belgium and Britain. Ecologists quickly denounced the “arrogance” of the European Economic Community, which financed some of the experiments. Of particular concern is

Written byAlexander Dorozynski
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

PARIS—Europeans this summer have gained intimate experience in an exercise they had viewed in the past as a strictly American sport: genetic engineers versus ecologists. The contest arose after a spate of reports revealed that field tests of modified bacteria and plants were under way in France, West Germany, Belgium and Britain. Ecologists quickly denounced the “arrogance” of the European Economic Community, which financed some of the experiments.

Of particular concern is the testing by France’s National Institute of Agronomical Research (INRA) of genetically altered bacteria in an open field in the heart of Burgundy, near Dijon. Benedikt Hoerlin, German representative at the EEC and spokesman for the Rainbow group, said the tests set a “grave precedent” and warned that they could lead to a "terrifying catastrophe.” Hoerlin also excoriated INRA for bypassing regulations concerning such experiments.

TheDijon experiment was begun quietly in March when INRA’s laboratory of soil microbiology ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies